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Abstract.  Considerable evidence implicates gp90 MEL 
as a lymphocyte homing receptor mediating lympho- 
cyte attachment to high endothelial venules of lymph 
nodes in mouse. The protein appears to function as a 
calcium-dependent,  lectin-like receptor as inferred pri- 
marily by the ability of specific carbohydrates to block 
its function and by the presence of a calcium-type lec- 
tin domain in its primary sequence.  An ELISA assay 
is described which provides the first demonstration 
that the isolated protein has lectin activity and allows 
a further definition of its carbohydrate specificity. In 
addition to the monosaccharides mannose-6-phosphate 
and fructose-I-phosphate, ligand activity is shown for 
the sulfated glycolipid, sulfatide, and for two sulfated 
fucose-containing polysaccharides (fucoidin and egg 
jelly coat) from nonmammalian  sources. 
I 
N most mammalian  species,  lymphocytes in the blood 
migrate  into  lymph nodes and  other  secondary lym- 
phoid  organs  by first  binding  to  the  endothelium  of 
specialized postcapillary venules known as high endothelial 
venules (HEVs) 1 (reviewed in Berg et al.,  1989; Duijvestijn 
and Hamann,  1989; Rosen, 1989; Stoolman,  1989; Wood- 
ruff et al.,  1987; Yednock and Rosen, 1989). Over a period 
of several minutes,  the lymphocytes migrate  across the en- 
dothelium and its associated basement membrane and gain 
access to the parenchyma of the lymphoid organ where se- 
questered and processed antigens are encountered. The initi- 
ating  adhesive  interaction  is  mediated  by  a  lymphocyte 
receptor,  operationally  termed  a  "homing  receptor  S that 
interacts  with a complementary HEV-ligand  expressed on 
the endothelial  cells of HEV.  The term "homing"  conveys 
the general  finding  that  different  lymphocyte populations 
show differential adhesive specificities for HEV (reviewed in 
Butcher,  1986).  The term "vascular  addressins" which has 
been applied to the HEV-ligands (Streeter et al.,  1988a, b), 
signifies that these adhesive ligands carry distinctive  recog- 
nition determinants  as a function of the anatomical site of the 
HEV. A current model of lymphocyte homing  (Butcher and 
Weissman,  1984), postulates that the complement of homing 
receptors expressed on a particular blood-borne lymphocyte 
is the primary factor in determining  which lymphoid organs 
it can enter. Adhesion molecules such as LFA-1 appear to be 
accessory to the homing  receptors in that they augment the 
strength of the lymphocyte-HEV interaction  without impart- 
ing lymphoid organ  selectivity (Hamann et al.,  1988; Pals 
et al., 1988). Two homing specificities, presumably based on 
two  sets  of nonoverlapping  homing  receptor/HEV-ligand 
1. Abbreviations used in this paper: F1P, fructose-l-phosphate;  HEV, high 
endothelial  venule;  M6P, mannose-6-phosphate;  PN,  peripheral  lymph 
node; PP, Peyer's patch. 
pairs, have been described, directing lymphocyte binding to 
HEV in peripheral lymph nodes (PNs) and in Peyer's patches 
(PPs) (Butcher et al.,  1980; Jalkanen  et al.,  1989; Schmitz 
et al.,  1988).  Still other "homing  specificities"  may be in- 
volved in  lymphocyte extravasation  into  other  lymphoid 
compartments and into sites of inflammation outside of orga- 
nized lymphoid organs  (Jalkanen  et al.,  1986; Sackstein  et 
al.,  1988).  In  the mouse,  the best characterized  homing 
receptor is gp90  mL, a =90-kD surface molecule defined by 
the mAb MEL-14 (Gallatin  et ai.,  1983). When pretreated 
with this  antibody,  lymphocytes are unable to bind to PN 
HEV but bind normally to PP HEV as measured in an in 
vitro adherence assay (Stamper and Woodruff,  1976). The 
occurrence of the MEL-14 mAb-defined epitope on various 
lymphocyte and lymphoma cell populations correlates with 
the ability of the cells to bind to PN HEV (Reichert et al., 
1983). Moreover, a direct adhesion role has recently been es- 
tablished for gp90  ~  by the finding that the isolated native 
protein (Geoffroy and Rosen, 1989) or a soluble recombinant 
form of the receptor (Watson et al., 1990) can interact selec- 
tively with PN HEV and block subsequent lymphocyte at- 
tachment. 
A  central  aspect of the studies  of gp90  mL concerns its 
function as a lectin-like receptor.  Early studies revealed that 
D-marmose-6-phosphate  (M6P) and o-fructose-l-phosphate 
(F1P), when compared to other phosphorylated monosac- 
charides,  selectively inhibit  the attachment of lymphocytes 
to PN HEV in rat (Stoolman et al., 1984), mouse (Yednock 
et ai., 1987b) and human (Stoolman et al., 1987). Addition- 
ally, the yeast-derived, M6P-rich phosphomannan  monester 
core from Hansenula hostii known as PPME, and the sul- 
fated, fucose-rich polysaccharide called fucoidin (from brown 
seaweed) were shown to be potent inhibitors of lymphocyte 
binding to PN HEV while having little effect on the binding 
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Yednock et al.,  1987b,  Yednock,  T.  A., M.  S.  Singer,  Y. 
Imai,  and  S.  D.  Rosen, manuscript in preparation).  With 
PPME-derivatized microbeads as a probe for cell surface 
receptors, it was demonstrated that the carbohydrate depen- 
dency of lymphocyte binding to PN HEV can be accounted 
for by a calcium-dependent,  lectin-like receptor on the lym- 
phocyte surface (Yednock et al.,  1987b;  Stoolman et al., 
1987; Stoolman and Ebling,  1989). Moreover,  experiments 
demonstrating  MEL-14 mAb inhibition of PPME bead bind- 
ing  to lymphocytes and  the coexpression of PPME bead 
binding with the MEL-14 epitope on lymphoma variants ar- 
gued that the receptor, detected by PPME beads, was closely 
related  and probably identical  to gp90  uEL (Yednock et al., 
1987a). In agreement  with this prediction,  molecular clon- 
ing of gp90  MEL (Lasky et al., 1989; Siegelman et al., 1989) 
has revealed a transmembrane protein with a calcium-depen- 
dent ("C-type") lectin motif of 117 residues positioned at its 
extracellular  amino terminus.  Among the homologous pro- 
teins, the best known are the mammalian  asialoglycoprotein 
receptors, the chicken hepatic lectin, and the mannose-bind- 
ing protein, all of which show calcium-dependent  carbohy- 
drate-binding  activity (reviewed by Drickamer,  1988). The 
MEL-14-defined epitope has been shown to map to the amino 
terminal region of the "lectin" domain (Bowen et al.,  1990). 
Following the sugar-binding motif in the predicted sequence 
of gp90  MEL are an EFG-like motif (34 residues),  two identi- 
cal complement-regulatory  motifs of 62 amino acids each, a 
transmembrane domain, and a short cytosolic tail of 17 amino 
acids. The arrangement of the three extracellular motifs (lec- 
tin/EGF/complement-regulatory)  in this murine  protein,  its 
human homologue (Bowen et al., 1989; Siegelman and Weiss- 
man, 1989; Tedder et al., 1989; Camerini et al., 1989; Ted- 
der et al., 1990; Kishimoto et al., 1990), and in two indepen- 
dent cell adhesion molecules (CAMs) (ELAM-1 [Bevilacqua 
et al., 1989] and GMP-140/PADGEM [Johnston et al., 1989]) 
has led to the suggestion of  the acronym LEC-CAM as a fam- 
ily designation (Stoolman, 1989). Bevilacqua, M. E, McEver, 
R.  P.,  and co-workers  (Geng et al.,  1990) have proposed 
the name "selectins" for the family. The present study de- 
scribes an ELISA assay that has been devised to measure 
the  interaction  between  immunoaffinity-purified  gp90  uEL 
and the carbohydrate-based ligand,  PPME. The results de- 
scribed herein establish  that gp90  MEL, as an isolated  mole- 
cule,  exhibits  calcium-dependent  lectin  activity with  the 
expected binding characteristics,  including the ability to rec- 
ognize fucoidin and a structurally related fucan from sea ur- 
chin egg jelly coat.  The assay further reveals that a sulfated 
glycolipid of widespread occurrence in mammalian  tissues 
(i.e., sulfatide) possesses ligand activity. It is concluded that 
the properties displayed by gp90  uEL in the ELISA assay ac- 
count for critical  adhesive  functions  manifested  by this re- 
ceptor at the lymphocyte surface. 
Materials and Methods 
Reagents 
Bovine brain sulfatide [Cral(3-SO4)/31-1Ceramide],  Gu3, galactosylceramide, 
cholesterol-3-sulfate, chondroitin sulfate A (bovine trachea), chondroitin sul- 
fate B (porcine skin), chondroitin sulfate C (shark cartilage),  colominic acid 
(E.  coli), heparan sulfate (bovine intestinal mucosa), hyaluronic acid (hu- 
man umbilical vein), keratan sulfate (bovine cornea), heparin (porcine in- 
testinal  mucosa),  N-acetylneuraminic  acid  (E.  coli),  sialyllactose  (85% 
,2-3 linkage and 159[ c~2-6, from bovine  colostrum), BSA (3-X crystallized), 
p-nitrophenylphosphate, polyoxyethylene sorbitan monolaurate  (Tween 20), 
and ascorbic acid were purchased from Sigma Chemical Co.  (St.  Louis, 
MO). All of the phospborylated monosaccharides were from Sigma Chemi- 
cal Co. and were in the sodium form except for GaI-I-P which was in the 
potassium form. Polyvinylsulfate  (potassium salt) and sodium rhodizonate 
were from Aldrich Chemical Co. (Milwaukee, WI). An independent sample 
of brain sulfatide was purchased from Matreya,  Inc.  (Pleasant Gap,  PA). 
Sulfatide was shown to be homogeneous by thin layer chromatography analy- 
sis. GMh GM2, Gnta, GD3, Crrtb, and GQlb were purchased from Calbio- 
chem-Behring Corp.  (La Jolla, CA); and C~tb from Bachem, Inc.  (Tor- 
rance, CA). Synthetic Gal(6-SO4)/31-1Cer, fucoidin, and heparins (porcine 
mucosal and bovine lung) were generous gifts from Dr. D. Roberts (Labora- 
tory of Structural Biology, National Institutes of Health, Bethesda, MD). 
Independent samples of fucoidin were purchased from ICN K&K Laborato- 
ries Inc. (Piainview, NY) and Sigma Chemical Co. PPME was purified from 
a crude yeast  mannan preparation kindly provided by Dr.  M. E.  Slodki 
(Department of Agriculture,  Northern Regional  Research  Center,  Peoria, 
IL).  Sea urchin egg jelly fucan from S. purpuratus was a generous gift of 
Dr. C. Glabe (Department of Molecular Biology and Biochemistry, Univer- 
sity  of California, Irvine, CA).  Sulfate  was  determined by the barium- 
rhodizonate method described by Silvestri et al. (1982). Biotinylated-goat 
anti-rabbit IgG (H +L) and Vectastain ABC-alkaline phosphatase kit were 
from Vector Laboratories, Inc. (Burlingame, CA). 3-[(3-cholamidopropyl)- 
dimethylammonio]-l-propanesulfonate  (CHAPS) and octyl/3-D-glucopyran- 
oside were from Boehringer Mannheim (Indianapolis,  IN). 
The anti-PPME antiserum was prepared by injecting a New  Zealand 
white rabbit with 100/~g of PPME emulsified in 2 ml of Freund's complete 
adjuvant (Difco Laboratories Inc., Detroit, MI). The antigen was adminis- 
tered in multiple  intradermal and subcutaneous  sites,  and the animal was 
bled 7 wk later. 
ELISA Assay 
gp90  MEL antigen, purified by immunoatiinity chromatography as previ- 
ously described (Lasky  et al.,  1989;  Geoffroy  and Rosen,  1989),  was 
equilibrated in Dulbecco's  PBS (0.68 mM calcium, 0.49 mM magnesium) 
containing either 1 mM CHAPS or 40 mM octyl/~-~glucopyranoside.  The 
PPME-binding activity of gp90  Mm- appeared to be more stable in octyl/3- 
D-ghicopyranoside than in CHAPS.  10/~1 of antigen solution at specified 
concentrations was diluted into 90/~1 of PBS in the wells of Immulon-2 mi- 
crotiter plates (Dynatech Laboratories, Inc., Chantilly,  VA). The dilution 
factor was chosen to reduce the detergent concentration below the critical 
micellar concentration. Adsorption was allowed  to proceed overnight at 
4°C. The wells were washed three times with PBS containing 0.1% Tween 
20 (PBS-Tween). 200/~1 of PBS containing 3% BSA and 0.02% NaN3 was 
then added to each well to block nonspecific binding sites. After a 2-h incu- 
bation at 22"C with agitation, the wells were washed and then received 100 
/~1 of PPME solution in 3% BSA-PBS or 3% BSA-PBS alone (control for 
background). After a 1-h incubation at 4°C, the wells were washed to re- 
move unbound polysaeehadde and 100/~1 of rabbit anti-PPME antiserum 
(1:100 dilution into 3% BSA in PBS-Twcen) was added to each well. This 
incubation and all subsequent incubations were allowed to proceed at 22"C 
with agitation.  After 1 h of exposure to anti-PPME, the wells were washed 
and 100 t~l per well of biotinylated goat anti-rabbit IgG (1:200 dilution into 
3 % BSA in PBS-Tween) was added and allowed to react for 1 h. The wells 
were again washed before the addition of 50/~1 per well of Vector ABC-AP 
reagent in PBS-Tween made according to the manufacturer's specifications. 
After 30 min, the wells were washed again and color development was initi- 
ated by the addition of 100/~1 per well of substrate solution (p-nitrophen- 
yiphosphate,  1 mg/mi in 10 % [vol/vol] diethanolamine-HCl  buffer, pH 9.8). 
Optical density readings were made at 405 nm with a (model 3550; BioRad 
Laboratories, Richmond, CA) microplate reader. Mean values were deter- 
mined for two to three replicate wells. With PPME added in excess, a satu- 
ration level of binding was observed at ~0.4/~g of gp90  M~ per well. In ex- 
periments measuring the ability of substances to compete with PPME for 
binding to immobilized glO0  Mm~, a concentration of 0.2-0.5/~g per well 
of gp90  Mea~ was added and the substances (diluted into 50/~1 of PBS) were 
allowed to react with the antigen for 1 h at 4"C. PPME (50 t~l, in 6% BSA- 
PBS) was added to each well, and the plate was incubated for an additional 
1 h at 4°C. The plate was then processed as described above. The concentra- 
tions of the inhibitors are expressed  as final concentrations after addition 
of the PPME. To test lipids as inhibitors, samples dissolved in chloroform- 
methanol 1:1 were dried in glass test tubes under a stream of nitrogen, and 
then suspended  in PBS by brief sonication (model D-50; Bransen Sonic 
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study were observed in at least two independent experiments. 
In Vitro Lymphocyte-HEV Adherence Assay 
The assay used was slightly modified from the original assay of Stamper 
and Woodruff (1976). This highly validated assay measures the binding of 
lymphocytes to profiles of HEV exposed in cryostat-cut sections of lym- 
phoid organs. Mouse peripheral lymph nodes (axillary, brachial, and cervi- 
cal) were sectioned and processed as previously described (Stoolman et al., 
1984). Lymphocytes  at 1 x  107 cells per ml were pretreated for 30 rain at 
4°C  with  the  aqueous  suspension  of  lipids  and  then  layered  over 
paraformaldehyde-fixed  tissue sections in the continued presence of the 
lipids. Lymphocyte attachment to HEV was measured by digital morphom- 
etry (Rosen et al., 1985) as the number of lympho~tes bound per unit area 
of HEV. Values were computed as percentages of control binding in the ab- 
sence of inhibitors. Four to five replicate slides were used for each ex- 
perimental condition and for the control condition. 
Results 
Development of  an ELISA Assay 
Our  strategy  took advantage  of previous  work  in  which 
transmembrane  adhesion  proteins  have been coated onto 
plastic  wells  in  a  functionally  active  form  (Martin  and 
Springer, 1987; Staunton et al.,  1989). Immunoatiinity-pu- 
rifled gpg0  MEL (>90% pure by SDS-PAGE analysis with sil- 
ver staining visualization) suspended in either CHAPS or 
octyl/~-D-glucopyranoside detergent was diluted into Dul- 
becco's PBS (containing calcium and magnesium) to reduce 
the detergent concentration below the critical micellar con- 
centration and then adsorbed overnight onto Immulon-2 mi- 
crotiter wells.  After washing of the wells and blockage of 
nonspecific sites with BSA, the wells were exposed to PPME 
in solution. PPME that bound to gp90  M~L in the wells was 
detected with an anti-PPME rabbit antiserum used in con- 
junction  with  a  biotinylated second  antibody  and  ABC- 
alkaline phosphatase. Quantification was accomplished with 
a spectrophotometric microtiter plate reader. Fig.  1 A dem- 
onstrates that the binding of PPME to immobilized gp90  u~ 
increased with increasing amounts of gp90  MEL added to the 
wells.  For a  fixed amount of gp90  M~,  saturation was ap- 
proached at a PPME concentration of >10 #g/ml (Fig. 1 B). 
Background, defined as the signal in the absence of added 
PPME, was subtracted from all values in these experiments 
and those that follow. Typically, this background represented 
<25-50% of the total signal but was very stable within each 
experiment. Assays carried out with preimmune serum pro- 
duced <10% of the signal seen with the anti-PPME serum. 
To confirm that gp90  M~L and not a contaminant was respon- 
sible for the PPME interaction, the effect of the MEL-14 
mAb was tested. As shown in Fig. 2, this antibody completely 
inhibited binding of PPME, whereas the class-matched con- 
trol antibody anti-T200 (30G12, anti-CD45) had no signifi- 
cant effect. As expected for a calcium-dependent lectin inter- 
action,  EGTA at  10 mM,  which reduced free calcium to 
'~10  -9 M,  completely blocked the interaction with PPME 
(Fig. 2). In a quantitative study of the calcium requirement, 
half-maximal  binding  of PPME  to  gp90  M~L  occurred  at 
'~,10  -5 M Ca  ~  in the presence or absence of 1 mM magnes- 
ium (Yednock, T. A., M. S. Singer, Y. Imai, and S. D. Rosen, 
manuscript in preparation). 
Effects of  Monosaccharides and Polysaccharides 
Our previous results  established that M6P and F1P were 
selective inhibitors of in vitro lymphocyte binding to PN 
HEV as compared to mannose-l-phosphate, fructose-6-phos- 
phate and  several other phosphorylated monosaccharides. 
When tested in the ELISA assay, these monosaccharides ex- 
hibited a similar inhibitory profile. 50% inhibition of PPME 
binding to gpg0  MEL (Fig. 3) was achieved at 7 mM for both 
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Figure L Binding of PPME to gp90  M~. (A) The indicated amounts of gp90  MEL were allowed to bind to the wells of a microtiter plate 
and then tested for PPME binding (final concentration of  20/xg/ml) as described in Materials and Methods. The y-axis indicates the optical 
density readings at 405 nm after subtraction of the background (no added PPME condition). The values represent means of duplicate 
determinations. Error bars denote half-ranges of variation. (B) Variable amounts of PPME were bound to a fixed amount of immobilized 
gp90  Mm- (0.4 #g added per well). The error bars indicate SEMs based upon three replicate determinations. 
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Figure 2.  Effects of MEL-14 mAb, T-200 mAb, and EGTA on 
PPME binding to gp90  MeL. Before addition of 50/~1 of PPME (2 
#g/ral) to immobilized gp90  ~EL, 50 /zl of MEL-14 mAb (50/~g/ 
ml), T-200 mAb (50 tzg/ml), 20 raM EGTA or 3% BSA-PBS  alone 
were added to the wells and allowed to incubate for 1 h at 4°C. The 
error bars indicate SEMs based upon three replicate determina- 
tions. The concentration of added gp90  MEL was 0.5 ttg per well. 
M6P and F1P, respectively, while M1P and F6P required two- 
to threefold higher concentrations. Galactose-l-phosphate, 
galactose-6-phosphate, and glucose-l-phosphate were equiv- 
alent to F6P (not shown). These differences among the phos- 
phorylated  monosaccharides  were  statistically  significant 
and were consistently observed in several experiments with 
different batches of sugars.  Neutral monosaccharides (D-man- 
nose, L-fucose, D-fucose, D-fructose, and D-galactose) were 
inactive in this assay at >400 mM (data not shown). Also, 
sialic acid as free 5 N-acetylneuraminic acid (Neu5Ac) or as 
sialyllactose was three- to fivefold less active on a molar ba- 
sis than M6P (not shown) and thus was comparable to F6P 
and the other relatively inactive phosphorylated monosac- 
charides. 
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Figure 3.  Effects of phosphorylated monosaccharides on PPME 
binding to gp90  MEL. The abscissa indicates the final sugar concen- 
tration. The concentration of added gp90  MEL was 0.3/~g/well and 
the amount of PPME was 0.1/~g/well. Values are means of  duplicate 
determinations. The error bars denote half ranges of variation. 
Among the charged polysaccharides, fucoidin and sea ur- 
chin egg jelly fucan (a sulfated fucose homopolysaccharide) 
were both  very potent inhibitors  on a  mass  basis  in  the 
ELISA assay (Fig. 4 A). With three different preparations of 
fucoidin  in  several experiments,  50%  inhibition was  ob- 
served at 0.1-0.4/xg/ml, equivalent to 1-4 nM, based on an 
average molecular weight of 100,000 D (Roberts and Gins- 
berg,  1988).  Hence,  on a  molar basis,  fucoidin was  six 
orders of magnitude more potent than M6P. The egg jelly fu- 
can, with a molecular weight >106 D was even more active 
than fucoidin per unit molecule. Other charged polysaccha- 
rides, including chondroitin sulfates A, B, and C, heparan 
sulfate, keratan sulfate, hyaluronic acid, and colominic acid 
(a homopolymer of ~ 2-8 linked sialic acid) were at least 
3,000-fold less active per unit weight than fucoidin or egg 
jelly fucan. On the basis of sulfate concentration, fucoidin 
and egg jelly fucan were also three orders of magnitude more 
effective than the other sulfated polysaccharides (Fig. 4 B) 
as well as polyvinylsulfate, a highly sulfated hydrocarbon. A 
direct comparison of the sulfate content of the various sul- 
fated compounds established that sulfate content was  not 
correlated with inhibitory efficacy (Table I). 
Effects of Glycolipids 
Preliminary experiments (True, D. D., unpublished observa- 
tions) had suggested that microspheres coated with sulfatide 
(i.e.,  Gal(3-SO4)/31-1-Cer)  could bind  to  mouse  lympho- 
cytes. Since this interaction was partially inhibited (•50%) 
by MEL-14 mAb and by EDTA, it seemed likely that sulfa- 
tide possessed ligand activity for gp90  MEL. To explore this 
possibility further, we determined whether brain sulfatide in 
an aqueous suspension could inhibit the binding of PPME to 
gp90  MEL in the ELISA assay.  Sulfatide at  10/~g/ml almost 
completely prevented PPME binding to immobilized gp90  M~- 
(Table II) with 50%  inhibition at '~1  /~g/ml or 1 /xM SO4 
(Fig. 4). Gal(6-SO4)fll-lCer, cholesterol 3-SO4,  galactosyl- 
ceramide (Galfll-lCer), and several gangliosides (GM1, GD~a, 
GDIb, Gzlb) had no activity at the same concentration and 
much less, if any,  activity when tested at a  10-fold higher 
concentration (Table U).  Additionally,  the gangliosides GM2, 
GM3, GD3, and GQtb showed little or no activity at 100 t~g/ml. 
Effect of Sulfaade on Lymphocyte Binding to HEV 
Consistent with the inhibitory effect of sulfatide on gp90  MEL 
in the ELISA assay, this glycolipid also blocked lymphocyte 
attachment to PN HEV in a dose-dependent manner in the 
in vitro adherence assay,  whereas Gal(6-SO4)-Cer and cho- 
lesterol-3-SO4 displayed minimal activity (Fig. 5). None of 
the lipids adversely affected the viability of the test lympho- 
cytes, as determined by trypan blue exclusion. 
Discussion 
Our previous studies had indicated a close relationship be- 
tween the calcium-dependent, lectin-like receptor detected 
on the lymphocyte cell surface by PPME and the protein 
(i.e., gp90  ~EL) recognized by the adhesion-blocking mAb, 
MEL-14. The finding of a C-type lectin domain at the ex- 
tracellular terminus of gp90  MEL lent strong support to the 
contention that the relationship was one of identity. Here, we 
establish identity by showing directly that immunoaffinity- 
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Figure 4. Effects of polysaccharides and sulfatide on PPME binding to gp90  M~. The following glycoconjugates were tested for their abil- 
ity to compete the binding of PPME (0.1 ttg/well) to immobilized gp90  Me~ (0.2/tg/well):  ([]) egg jelly fucan; (~) fucoidin (Sigma Chemi- 
cal Co.); (I) chondroitin sulfate B; (o) chondroitin sulfate C; (v) heparan sulfate; A, sulfatide; (4) keratan sulfate; (n) hyaluronic acid; 
and (o) colominic acid. Chondroitin sulfate A was also tested and found to be inactive at 1,000/~g/nd (not shown). Values are means 
of duplicate determinations. The half ranges of variation were typically <8 % of the means. (A) Glycoconjugate concentrations are given 
as/~g/ml.  (B) Concentrations are specified on the basis of sulfate concentration as determined for each glycoconjugate by the barium- 
rhodizonate method. 
purified  gp90  MEL,  immobilized  on  plastic,  can  bind  to 
PPME with the predicted characteristics. As determined in 
the  ELISA  assay,  the  interaction  is  saturable,  calcium- 
dependent, and selectively inhibited by MEL-14 mAb. With 
respect to sugar inhibition, MtP and F1P are two to threefold 
more active than M1P and F6P in competing PPME binding 
to  gp90  MEL, in  agreement  with  the  relative  activities  of 
these sugars in blocking both PPME bead binding to lym- 
Table L Sulfate Contents and Inhibitory Activities of 
Sulfated Macromolecules 
Concentration for 
Substance  SO4  50%  inhibition 
nmol/l~g  /~g/ml 
sulfatide (Matreya,  Inc.)  0.7  ND 
sulfatide (Sigma Chemical Co.)  0.8  0.7-1.3 
cholesterol-3-sulfate  1.2  >100 
chondroitin sulfate A  1.4  >1,000 
chondroitin sulfate B  1.6  >1,000 
chondroitin sulfate C  1.8  >1,000 
keratan sulfate  t.8  >1,000 
fucoidin (Sigma Chemical Co.)  2.1  ND 
heparan sulfate  2.1  >1,000 
fucoidin (ICN K&K Laboratories)  2.5  0.1-0.4 
heparin (porcine intestinal)  2.8  100 
heparin (bovine lung)  3.0  19 
heparin (porcine mucosa)  3.0  110 
egg jelly fucan  3.4  0.2 
polyvinylsulfate  6.0  >1,000 
The substances listed were analyzed for sulfate content. The valfies represent 
means of duplicate determinations. The half-range variations were <2 % of the 
means in all cases. Substances are listed in order of increasing sulfate content. 
Concentrations for 50% inhibition in the ELISA assay were determined from 
the dose-response curves of Fig. 4 and from dose-response curves not shown. 
phocytes and lymphocyte attachment to PN HEV (Yednock 
et al.,  1987b). Fucoidin, a fucose-rich polysaccharide with 
sulfation primarily on the 4-position of fucose (DeAngelis 
and Glabe, 1987), is substantially more potent than PPME 
as an inhibitor of lymphocyte attachment to PN HEV (Yed- 
nock et al., 1987b; Stoolman et al., 1984). Heretofore, it has 
not been clear whether this polysaccharide achieves inhibi- 
tion of lymphocyte attachment to HEV by binding to the 
same subsite of gp90  M~L or even to the same receptor as 
PPME (Brandley et al.,  1987;  Yednock et al.,  1987a). We 
have now shown that fucoidin directly blocks PPME binding 
to gp90  MEL in the ELISA assay and thus appears capable of 
a direct interaction with this lymphocyte receptor. The sea 
urchin egg jelly fucan, a  homopolysaccharide of L-fucose 
with sulfation on the C-4 position of the sugar and hence 
clearly related to fucoidin (DeAngelis and Glabe, 1987), is 
even more active as an inhibitor.  Testing of several other 
charged polysaccharides (hyaluronic acid, colominic acid, 
heparins, chondroitin sulfates, and keratan sulfate) and a sul- 
fated hydrocarbon, many of which  have charge densities 
comparable to  or  exceeding that of the  fucans  (Table I; 
DeAngelis and Glabe, 1987), establishes that the inhibitory 
effects of the fucans are highly selective and cannot merely 
be explained on the basis of charge density. 
In an attempt to identify additional carbohydrate-based in- 
hibitors of the PPME/gp90  M~ interaction, we tested a  se- 
ries  of glycolipids in the  ELISA assay.  Sulfatide  [Gal(3- 
SO,)~l-lCer],  which  preliminary  experiments  indicated 
might interact with gp90  M~, is now confirmed to be active, 
In contrast,  cholesterol-3-sulfate and the  synthetic glyco- 
lipid,  Gal(6-SO4)/31-1Cer are substantially less active. The 
presence of  the sulfate moiety is critical to sulfatide's activity, 
since galactosylceramide (Gal/31-1Cer) is inactive. The func- 
tional relevance of these observations with the ELISA assay 
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Expert- 
ment  Inh~b~tor  OD 405 nm 
/ag/ml 
1  None  -  0 596  +  0 025 
Sulfat~de (Sigma Chermcal Co )  10  0 030  +  0 005 
Sulfatule (Matreya, Inc )  10  0 019 + 0 006 
Galaetosylceranude  10  0 668 4- 0 021 
Gal(6-SO~)/51-1Cer  10  0 612 4- ,0,,016 
Cholesterol 3-SO~  10  0 583 4- 0 014 
2  None  -  0 291  4- 0 065 
Sulfattde (S~gma Chermcal Co )  10  0 023 4- 0 018 
GM~  10  0 208 4- 0 014 
GDla  10  O 328 4- 0 017 
GDIb  10  (J 256 4- 0 053 
GT~b  10  0 287 4- 0 017 
3  None  -  0 362 4- 0 064 
Sulfatlde (Matreya, Inc )  100  0 0 
GM~  100  0 310 + 0 026 
Gm  100  0 248 + 0  042 
GM3  100  0 378 4- 0 019 
4  None  -  0 431  4- 0 047 
Sulfat~de (Matreya, Inc )  10  0 0 
GDIa  100  0 331  4- 0 025 
GD~b  100  0 313 4- 0 011 
GT~b  100  0 257 4- 0 026 
Go3  100  0 555 4- 0 021 
Go~b  100  0 288 4- 0 032 
The substances were tested m  the ELISA assay as described under Materials 
and Methods  The errors denote SEMs based upon three rephcate detemuna- 
taons  Structures  of Glyeohptds  Galactosylceramute,  Gal/~l-lCer, Sulfatlde, 
Gal(3-SO41)/~l-lCer, Gin, GalB1-3OalNAe/31-4[NeuSAe,~,2-3]Gal/~l-4Gle/~l- 
1Cer,  Go~,, NeuAea2,3Gal31-3GalNac/~l-4[NeuAeu2-3]Gal/~l-4Gle/~l-lCer, 
Grab, Gal~l-3GalNAcgl-4[NeuAeet2-8NeuAcxt2-3]Gal#l-4Gle/~l-lCer,  Gnu, 
NeuAct~2-3GalB  1-3GalNAe/~I-4[NeuAet~2-8NeuAeot2-3]GalB  1-4Glc~ 1  - 1Cer, 
Gin,  GalNAc/~l-4[NeuAect2-3]Gal/~l-4GIcgl-lCer,  Gu~, NeuAccd-3Gal/~l- 
4Glegl-lCer  Gin, NeuAeot2-8NeuAeot2-3GalB1-4GleBl-lCer, GOSh, NeuAea2- 
8NettAcct2-3Gal/~1-3GalNAeOl-4[NeuAeot2-8NeuAc2-3]Gal~  1-4GIe~  1  - 1Cer 
is borne out by direct lymphocyte  adhesion assays  Sulfatlde, 
hke PPME and fucoldm, inhibits  lymphocyte attachment to 
PN HEV m the Stamper-Woodruff m wtro adherence assay, 
while Gal(6-SO0~l-lCer and cholesterol-3-sulfate are essen- 
tially macUve at the concentrations tested  On a molar bas~s, 
Gal(3-SO0~l-lCer is over three orders of magmtude more 
potent than M6P m both the m wtro adherence assay and the 
ELISA assay  It seems probable that the enhanced efficacy 
of sulfatade (monomerlc molecular weight of 807) relatave to 
M6P and F1P derives, at least m part, from its nucellar orga- 
mzataon  m aqueous solution  Smularly, the high avlchty of 
PPME for munobthzed gp90  u~- (Fig  1 B) is hkely attribut- 
able to the muluvalent presentaUon of M6P residues m the 
polysacchande 
The C-type lecUn domain of gp90  M~L is almost certainly 
revolved m the binding of the intact receptor to PPME  In 
ad&Uon to the sugar selecuvlty of the mteracuon and the re- 
quirement for calcmm (two hallmarks of a  C-type lectm), 
PPME binding is blocked by the MEL-14 mAb, which de- 
tects an epltope in the lectm domain of gp90  MEL (Bowen et 
al  , 1990)  Based on their acUvlty m competang PPME bind- 
ing m the ELISA assay, it seems hkely that the fucans as well 
as sulfaUde also mteract with the lectm domain of gp90  MBL, 
% Control 
Binding to HEV 
120- 
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80- 
60. 
40- 
20. 
0  i  ,  i 
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F,  gure 5  Effects of sulfated hp~ds on lymphocyte attachment to PN 
HEV  Lymphocytes, exposed to hplds at the m&cated concentra- 
uons,  were tested for their ability to attach to PN HEV m the 
Stamper-W6bdruff m wtro adherence assay as described m Mate- 
rials and Methods Binding is computed as a p~reentage of the con- 
trol value deterrmned m the absence of added hpld  Error bars de- 
note SEMs computed from four to five replicate tissue sectaons 
The symbols are  (A) sulfaude, (~) Gal(6-SO4)Bl-lCer, and (.) 
cholesterol-3-SO4 
but these pre&caons remain to be confirmed m &feet bind- 
ing assays. 
It would be saUsfymg to account for the most acuve carbo- 
hydrates in the ELISA assay on the basis of some common 
structural moUf  M6P and F1P do share structural features, 
which appear to account for their highly selecuve binding to 
lysosomal  somng  receptors  (Tong  and  Kornfeld,  1989) 
However,  m  the case of the gp90 MEL the thfference m  po- 
tency between these  sugars  and the other phosphorylated 
sugars is not sufficiently great to warrant the proposal of a 
detailed model  Moreover, our finding that fucans and sul- 
fatlde are highly acuve relative to other charged polysac- 
chandes and glycollplds does not justify modeling on the 
basis of their consUtuent sugars 0 e,  fucose-4-sulfate and 
galactose-3-sulfate),  since  the  potentaal  contrlbutaons  of 
glycosl&c hnkage and mulUvalency to the acUwty of these 
glycoconjugates  are not known at present  The eventual ~den- 
aficaUon of monosaccharldes or structurally-defined ohgo- 
saccharldes with potent and selecUve  inhibitory actlviUes 
will greatly facflRate efforts to elucidate the cnUcal features 
of carbohydrate  structure  requLred for rec,  ograUon by gp90  u~ 
Our previous work has shown that gp90  MsL funcUons as 
an adhesion molecule by binding directly to the endothehum 
of PN HEV through an lnteracuon with an as yet uncharac- 
terlzed HEV-hgand  It Is also known that the lectm actwlty 
of  gp90  MEL  is  reqmred  for  Rs  mteracUon  with  the  en- 
dothelmm (Geoffrey and Rosen, 1989, Watson et al, 1990) 
Consequently,  mhlbRory sugars for gp90  MBL (e g, M6E F1P, 
etc ) are presumed to be structural mmucs of a carbohydrate 
recogmUon determinant present on the HEV-hgand  Since 
the mhlbRory sugars are all anlomc, R is strongly suspected 
that the actual recogmUon determinant is a negauvely charged 
carbohydrate  Addluonally, the  fact that the C-type lectm 
motif of gp90  MEL contains  significantly more basic attune 
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tent with the possibility of a negatively charged sugar ligand 
(Lasky et al.,  1989).  In this regard,  it is intriguing that the 
PN HEV-ligand is inactivated  by sialidases or by pretreat- 
ment of the HEV with L/maxflavus agglutinin, a sialic acid- 
specific lectin (Rosen et al., 1989;  Rosen et al., 1985;  True, 
D. D., M.  S. Singer,  L. A. Lasky,  and S. D. Rosen, manu- 
script submitted for publication).  Despite the fact that free 
sialic acid (Neu5Ac) and various glycosidically-linked forms 
of sialic acid (e.g.,  sialyllactose,  colominic acid, and gan- 
gliosides) do not compete effectively in the ELISA assay, it 
remains to be determined whether sialic acid (perhaps  in an 
unusual  form or linkage) is a recognition determinant of the 
HEV-ligand. (Sialic acid has considerable informational po- 
tential  in that it occurs in nature in a multitude of different 
forms and linkages [Schauer,  1985].) 
In view of the activity of sulfatide  and sulfated  fucans in 
the ELISA assay, sulfated glycoconjugates must also be con- 
sidered as possible candidates for the HEV-ligand.  Interest- 
ingly,  HEVs are  notable  for their high level of sulfate  in- 
corporation into macromolecules,  but little information is 
available about the biochemical nature of these sulfated mac- 
romolecules (Andrews et al., 1982,  1983). Among the pro- 
minent sulfated macromolecules  found in higher cells are 
sulfated glycosaminoglycans.  However, the results obtained 
with the ELISA assay indicate that the most commonly oc- 
curring  forms of these glycosaminoglycans (heparin, hepa- 
ran sulfate, keratan  sulfate, chondroitin sulfate)  are not di- 
rectly involved as HEV-ligands. Although sulfatide is present 
in various mammalian tissues (reviewed in Roberts,  1987; 
Roberts and Ginsberg,  1988), there is no information on its 
occurrence in HEV.  However, the HEV-ligand  for gp90 MBL 
is unlikely to be a glycolipid, since the binding sites on PN 
HEV for a soluble recombinant  form of gp90  MEL are not sub- 
stantially affected by extraction of the tissue with chloroform- 
methanol-H20 solvent mixtures (Rosen, S. D., M.  S. Singer, 
and L. A. Lasky, unpublished observation). An immunolog- 
ically defined candidate  for the HEV-ligand  of gp90  u~L is 
the antigen recognized by the MECA-79 mAb (Streeter et al., 
1988b).  This antibody reacts preferentially with PN HEV and 
blocks lymphocyte attachment  to the HEV.  Future  experi- 
ments must address whether the MECA-79 antigen or an as- 
sociated molecule contains a carbohydrate  determinant that 
is recognized by gp90  MEL. The identification  and structuring 
of this postulated carbohydrate  represent extremely impor- 
tant areas  for future  investigation. 
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